Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
Clinical trial NCT01092182 · COMPLETED
Trial details
- NCT number
- NCT01092182
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-25
- Primary completion
- 2020-09-30
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.